By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sandoz, Inc. 

506 Carnegie Center Drive, Suite 400

Princeton  New Jersey  08540  U.S.A.
Phone: 609-627-8500 Fax: 609-627-8683




Company News
Sandoz Expands Partnership With World Child Cancer, To Help Children Access Treatment In Four Developing Countries 7/25/2017 11:44:51 AM
Amphastar (AMPH) Announces Jury Verdict In Patent Litigation Against Momenta (MNTA) And Sandoz 7/24/2017 11:28:54 AM
DURECT (DRRX)'s Collaboration With Sandoz Clears HSR Review And Is Effective 6/19/2017 8:53:07 AM
FDA Accepts Sandoz Regulatory Submission For A Generic Version Of Advair Diskus 6/19/2017 5:15:17 AM
Apobiologix Applauds Supreme Court Decision In Sandoz Biosimilar Case 6/13/2017 7:23:24 AM
Sandoz Proposed Biosimilars Adalimumab And Infliximab Accepted For Regulatory Review By The EMA 5/31/2017 10:56:32 AM
Sandoz Proposed Biosimilars Rituximab And Etanercept Recommended For Approval In Europe* 4/24/2017 11:43:48 AM
New Data Demonstrate Sandoz Proposed Biosimilar Adalimumab Has Equivalent Efficacy To Reference Medicine 3/6/2017 6:54:30 AM
Sandoz Launches Generic Version Of Emend Capsules 1/4/2017 10:16:00 AM
Sandoz To Donate Up To USD 10 Million Of High-Quality Generic Medicines Annually To Americares To Increase Access To Medicines 11/22/2016 9:19:55 AM